Hiroki Shichi
Kobe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Newer parameters of the octreotide test in patients with acromegaly.
Journal: Pituitary
Published: October 23, 2023
Effects of the Cortisol Milieu on Tumor-Infiltrating Immune Cells in Corticotroph Tumors.
Journal: Endocrinology
Published: August 01, 2023
Case report: Late middle-aged features of FAM111A variant, Kenny-Caffey syndrome type 2-suggestive symptoms during a long follow-up.
Journal: Frontiers in endocrinology
Published: October 18, 2022
Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors.
Journal: Journal of the Endocrine Society
Published: September 30, 2022
Survey of glucocorticoid dose escalation in patients with adrenal insufficiency during the peri-COVID-19 vaccination period.
Journal: Endocrine journal
Published: September 14, 2022
Temozolomide and Capecitabine Treatment for an Aggressive Somatotroph Pituitary Tumor: A Case Report and Literature Review.
Journal: Frontiers in oncology
Published: April 10, 2022
Relation between the insulin lowering rate and changes in bone mineral density: Analysis among subtypes of type 1 diabetes mellitus.
Journal: Journal of diabetes investigation
Published: January 08, 2022
The Effect of Aging on Quality of Life in Acromegaly Patients Under Treatment.
Journal: Frontiers in endocrinology
Published: November 21, 2021
Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay.
Journal: Pituitary
Published: October 29, 2021
Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome.
Journal: Cancer immunology, immunotherapy : CII
Published: November 13, 2020
Last Updated: 09/26/2026